Human Microdialysis
Journal:
Current Pharmaceutical Biotechnology
Volume:
3
Page:
165-178
Author(s):
M. Stahl, R. Bouw, A. Jackson and V. Pay
Adenoviral Vectors for Cancer Gene Therapy
Journal:
Current Genomics
Volume:
3
Page:
163-180
Author(s):
Wenli Zhao, Masanobu Kobayashi, Masuo Hosokawa and Prem Seth
Mutant Epidermal Growth Factor Receptors as Targets for Cancer Therapy
Journal:
Current Cancer Drug Targets
Volume:
2
Page:
91-102
Author(s):
I. A.J. Lorimer
Annexins as Neuroprotective Agents in the Central Nervous System
Journal:
Current Medicinal Chemistry - Central Nervous System Agents
Volume:
2
Page:
87-107
Author(s):
Joanna Bandorowicz-Pikula
Use of the Bradykinin Agonist, Cereport as a Pharmacological Means of Increasing Drug Delivery to the CNS
Journal:
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume:
2
Page:
109-123
Author(s):
Dwaine F. Emerich
Adenovirus As An Integrating Vector
Journal:
Current Gene Therapy
Volume:
2
Page:
135-144
Author(s):
K. Mitani and S. Kubo
Second Generation Adeno-Associated Virus Type 2-based Gene Therapy Systems with the Potential for Preferential Integration into AAVS1
Journal:
Current Gene Therapy
Volume:
2
Page:
145-159
Author(s):
Roland A. Owens
Oncolytic Viruses: Programmable Tumour Hunters
Journal:
Current Gene Therapy
Volume:
2
Page:
243-254
Author(s):
J. C. Bell, K. A. Garson, B. D. Lichty and F. D. Stojdl
Cancer Gene Therapy with Tissue Inhibitors of Metalloproteinases (TIMPs)
Journal:
Current Gene Therapy
Volume:
2
Page:
255-271
Author(s):
Karsten Brand
Cyclic ADP-ribose (cADPR) and Nicotinic Acid Adenine Dinucleotide Phosphate (NAADP): Novel Regulators of Ca 2+-Signaling and Cell Function
Journal:
Current Molecular Medicine
Volume:
2
Page:
273-282
Author(s):
Andreas H. Guse